IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
696.64
-10.01 (-1.42%)
Nov 10, 2026, 4:00 PM EST - Market closed
IDEXX Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,662 | 4,304 | 3,898 | 3,661 | 3,367 | 3,215 | |
Revenue Growth | 11.87% | 10.42% | 6.46% | 8.72% | 4.73% | 18.80% |
Cost of Revenue | 1,738 | 1,644 | 1,519 | 1,471 | 1,363 | 1,326 |
Gross Profit | 2,924 | 2,660 | 2,379 | 2,190 | 2,004 | 1,889 |
Selling, General & Admin | 1,142 | 1,048 | 969.3 | 901.89 | 850.75 | 796.4 |
Research & Development | 266.87 | 251.21 | 219.79 | 190.95 | 254.82 | 161.01 |
Operating Expenses | 1,409 | 1,300 | 1,189 | 1,093 | 1,106 | 957.4 |
Operating Income | 1,515 | 1,360 | 1,190 | 1,097 | 898.77 | 932.03 |
Interest Expense | -34.59 | -38.85 | -31.21 | -41.58 | -39.86 | -29.81 |
Interest & Investment Income | 2.76 | 3.01 | 12.7 | 5.63 | 1.07 | 0.43 |
EBT Excluding Unusual Items | 1,483 | 1,324 | 1,171 | 1,061 | 859.97 | 902.65 |
Legal Settlements | -9 | - | -61.5 | - | - | - |
Pretax Income | 1,479 | 1,324 | 1,110 | 1,061 | 859.97 | 902.65 |
Income Tax Expense | 296.78 | 264.73 | 221.96 | 216.13 | 180.88 | 157.81 |
Earnings From Continuing Operations | 1,182 | 1,059 | 887.87 | 845.04 | 679.09 | 744.84 |
Minority Interest in Earnings | - | - | - | - | - | 0 |
Net Income | 1,182 | 1,059 | 887.87 | 845.04 | 679.09 | 744.85 |
Net Income to Common | 1,182 | 1,059 | 887.87 | 845.04 | 679.09 | 744.85 |
Net Income Growth | 15.06% | 19.33% | 5.07% | 24.44% | -8.83% | 28.03% |
Shares Outstanding (Basic) | 79 | 80 | 82 | 83 | 84 | 85 |
Shares Outstanding (Diluted) | 80 | 81 | 83 | 84 | 85 | 87 |
Shares Change | -2.19% | -2.67% | -0.87% | -0.73% | -2.28% | -0.17% |
EPS (Basic) | 14.90 | 13.17 | 10.77 | 10.17 | 8.12 | 8.74 |
EPS (Diluted) | 14.83 | 13.08 | 10.67 | 10.06 | 8.03 | 8.60 |
EPS Growth | 17.70% | 22.59% | 6.06% | 25.28% | -6.63% | 28.17% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1,304 | 1,057 | 808.08 | 772.88 | 394.15 | 636 |
Free Cash Flow Per Share | 16.35 | 13.05 | 9.71 | 9.20 | 4.66 | 7.35 |
Gross Margin | 62.72% | 61.80% | 61.04% | 59.82% | 59.52% | 58.76% |
Operating Margin | 32.50% | 31.60% | 30.53% | 29.97% | 26.69% | 28.99% |
Profit Margin | 25.36% | 24.62% | 22.78% | 23.08% | 20.17% | 23.16% |
Free Cash Flow Margin | 27.97% | 24.56% | 20.73% | 21.11% | 11.71% | 19.78% |
EBITDA | 1,673 | 1,505 | 1,320 | 1,212 | 1,011 | 1,037 |
EBITDA Margin | 35.89% | 34.98% | 33.86% | 33.11% | 30.01% | 32.24% |
D&A For EBITDA | 158.02 | 145.18 | 129.94 | 114.91 | 111.9 | 104.6 |
EBIT | 1,515 | 1,360 | 1,190 | 1,097 | 898.77 | 932.03 |
EBIT Margin | 32.50% | 31.60% | 30.53% | 29.97% | 26.69% | 28.99% |
Effective Tax Rate | 20.07% | 19.99% | 20.00% | 20.37% | 21.03% | 17.48% |
Revenue as Reported | 4,662 | 4,304 | 3,898 | 3,661 | 3,367 | 3,215 |
Advertising Expenses | - | 4 | 3.4 | 4.2 | 5 | 3.3 |